Notably, the observed variability in efficacy between agents, particularly in the early phases of treatment, emphasizes the importance of individualized therapeutic strategies, tailored to specific clinical goals, baseline metabolic profiles, and patient preferences
However, clinicians should remain vigilant for any changes in neurological status, as the metabolic improvements from better diabetes control may occasionally necessitate adjustments to Parkinson's medications
Retatrutide is a synthetic peptide developed for metabolic and endocrine research involving obesity, glycemic control, and multiple metabolic pathways
Individual responses to GLP-1 therapy are influenced by baseline health status, concurrent medications, dietary habits, and lifestyle factors